Search Results

By Hannah Dzimitrowicz, MD, and Andrew J. Armstrong, MD, ScM, FACP  / November 25, 2021

Taking Akt-ion Against Prostate Cancer?

Inhibition of the androgen receptor pathway (AR) with novel hormonal therapies such as abiraterone acetate has greatly improved outcomes for patients with metastatic castration-resistant prostate cancer in recent years. However, through numerous mechanisms, tumors ultimately develop resistance...